Market Surge: Mullen Gains Momentum, Pfizer's Investment Fuels Caribou Biosciences
- July 06th, 2023
- 501 views
Shares of Mullen Automotive, Inc. (Nasdaq: MULN) surged over 60% in pre-market trading after the company announced a $25 million stock buyback program authorized through December 31, 2023.
Mullen believes that its stock is significantly undervalued and trading at a substantial discount compared to its cash position of approximately $235 million.
In pre-market, $MULN is trading at $0.27, reflecting a notable increase of $0.10 (63.25%) following the announcement.
In other news, Caribou Biosciences, Inc. (Nasdaq: CRBU) has announced that Pfizer Inc. (NYSE: PFE) has invested $25 million in the company, purchasing 4,690,431 of its common shares at a price of $5.33 per share.
Caribou views Pfizer's investment as a validation of the potential of its clinical programs.
$CRBU is currently trading at $5.58 in pre-market, up $1.50 (36.76%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login